340 related articles for article (PubMed ID: 28087229)
1. Disease-associated mutations identify a novel region in human STING necessary for the control of type I interferon signaling.
Melki I; Rose Y; Uggenti C; Van Eyck L; Frémond ML; Kitabayashi N; Rice GI; Jenkinson EM; Boulai A; Jeremiah N; Gattorno M; Volpi S; Sacco O; Terheggen-Lagro SWJ; Tiddens HAWM; Meyts I; Morren MA; De Haes P; Wouters C; Legius E; Corveleyn A; Rieux-Laucat F; Bodemer C; Callebaut I; Rodero MP; Crow YJ
J Allergy Clin Immunol; 2017 Aug; 140(2):543-552.e5. PubMed ID: 28087229
[TBL] [Abstract][Full Text] [Related]
2. Activated STING in a vascular and pulmonary syndrome.
Liu Y; Jesus AA; Marrero B; Yang D; Ramsey SE; Sanchez GAM; Tenbrock K; Wittkowski H; Jones OY; Kuehn HS; Lee CR; DiMattia MA; Cowen EW; Gonzalez B; Palmer I; DiGiovanna JJ; Biancotto A; Kim H; Tsai WL; Trier AM; Huang Y; Stone DL; Hill S; Kim HJ; St Hilaire C; Gurprasad S; Plass N; Chapelle D; Horkayne-Szakaly I; Foell D; Barysenka A; Candotti F; Holland SM; Hughes JD; Mehmet H; Issekutz AC; Raffeld M; McElwee J; Fontana JR; Minniti CP; Moir S; Kastner DL; Gadina M; Steven AC; Wingfield PT; Brooks SR; Rosenzweig SD; Fleisher TA; Deng Z; Boehm M; Paller AS; Goldbach-Mansky R
N Engl J Med; 2014 Aug; 371(6):507-518. PubMed ID: 25029335
[TBL] [Abstract][Full Text] [Related]
3. Brief Report: Blockade of TANK-Binding Kinase 1/IKKɛ Inhibits Mutant Stimulator of Interferon Genes (STING)-Mediated Inflammatory Responses in Human Peripheral Blood Mononuclear Cells.
Frémond ML; Uggenti C; Van Eyck L; Melki I; Bondet V; Kitabayashi N; Hertel C; Hayday A; Neven B; Rose Y; Duffy D; Crow YJ; Rodero MP
Arthritis Rheumatol; 2017 Jul; 69(7):1495-1501. PubMed ID: 28426911
[TBL] [Abstract][Full Text] [Related]
4. Lung Inflammation in STING-Associated Vasculopathy with Onset in Infancy (SAVI).
David C; Frémond ML
Cells; 2022 Jan; 11(3):. PubMed ID: 35159128
[TBL] [Abstract][Full Text] [Related]
5. Novel TMEM173 Mutation and the Role of Disease Modifying Alleles.
Keskitalo S; Haapaniemi E; Einarsdottir E; Rajamäki K; Heikkilä H; Ilander M; Pöyhönen M; Morgunova E; Hokynar K; Lagström S; Kivirikko S; Mustjoki S; Eklund K; Saarela J; Kere J; Seppänen MRJ; Ranki A; Hannula-Jouppi K; Varjosalo M
Front Immunol; 2019; 10():2770. PubMed ID: 31866997
[TBL] [Abstract][Full Text] [Related]
6. Case Report: Novel SAVI-Causing Variants in
Lin B; Torreggiani S; Kahle D; Rumsey DG; Wright BL; Montes-Cano MA; Silveira LF; Alehashemi S; Mitchell J; Aue AG; Ji Z; Jin T; de Jesus AA; Goldbach-Mansky R
Front Immunol; 2021; 12():636225. PubMed ID: 33833757
[TBL] [Abstract][Full Text] [Related]
7. Overview of STING-Associated Vasculopathy with Onset in Infancy (SAVI) Among 21 Patients.
Frémond ML; Hadchouel A; Berteloot L; Melki I; Bresson V; Barnabei L; Jeremiah N; Belot A; Bondet V; Brocq O; Chan D; Dagher R; Dubus JC; Duffy D; Feuillet-Soummer S; Fusaro M; Gattorno M; Insalaco A; Jeziorski E; Kitabayashi N; Lopez-Corbeto M; Mazingue F; Morren MA; Rice GI; Rivière JG; Seabra L; Sirvente J; Soler-Palacin P; Stremler-Le Bel N; Thouvenin G; Thumerelle C; Van Aerde E; Volpi S; Willcocks S; Wouters C; Breton S; Molina T; Bader-Meunier B; Moshous D; Fischer A; Blanche S; Rieux-Laucat F; Crow YJ; Neven B
J Allergy Clin Immunol Pract; 2021 Feb; 9(2):803-818.e11. PubMed ID: 33217613
[TBL] [Abstract][Full Text] [Related]
8. Type I interferon-independent T cell impairment in a Tmem173 N153S/WT mouse model of STING associated vasculopathy with onset in infancy (SAVI).
Siedel H; Roers A; Rösen-Wolff A; Luksch H
Clin Immunol; 2020 Jul; 216():108466. PubMed ID: 32470544
[TBL] [Abstract][Full Text] [Related]
9. A rare manifestation of STING-associated vasculopathy with onset in infancy: a case report.
Weidler S; Koss S; Wolf C; Lucas N; Brunner J; Lee-Kirsch MA
Pediatr Rheumatol Online J; 2024 Jan; 22(1):9. PubMed ID: 38178067
[TBL] [Abstract][Full Text] [Related]
10. Severe combined immunodeficiency in stimulator of interferon genes (STING) V154M/wild-type mice.
Bouis D; Kirstetter P; Arbogast F; Lamon D; Delgado V; Jung S; Ebel C; Jacobs H; Knapp AM; Jeremiah N; Belot A; Martin T; Crow YJ; André-Schmutz I; Korganow AS; Rieux-Laucat F; Soulas-Sprauel P
J Allergy Clin Immunol; 2019 Feb; 143(2):712-725.e5. PubMed ID: 29800647
[TBL] [Abstract][Full Text] [Related]
11. STING-Mediated Lung Inflammation and Beyond.
Frémond ML; Crow YJ
J Clin Immunol; 2021 Apr; 41(3):501-514. PubMed ID: 33532887
[TBL] [Abstract][Full Text] [Related]
12. Positive feedback regulation of type I interferon by the interferon-stimulated gene STING.
Ma F; Li B; Yu Y; Iyer SS; Sun M; Cheng G
EMBO Rep; 2015 Feb; 16(2):202-12. PubMed ID: 25572843
[TBL] [Abstract][Full Text] [Related]
13. A Mutation Outside the Dimerization Domain Causing Atypical STING-Associated Vasculopathy With Onset in Infancy.
Saldanha RG; Balka KR; Davidson S; Wainstein BK; Wong M; Macintosh R; Loo CKC; Weber MA; Kamath V; ; ; Moghaddas F; De Nardo D; Gray PE; Masters SL
Front Immunol; 2018; 9():1535. PubMed ID: 30038614
[TBL] [Abstract][Full Text] [Related]
14. Type 1 interferonopathy presenting as juvenile idiopathic arthritis with interstitial lung disease: report of a new phenotype.
Clarke SLN; Robertson L; Rice GI; Seabra L; Hilliard TN; Crow YJ; Ramanan AV
Pediatr Rheumatol Online J; 2020 May; 18(1):37. PubMed ID: 32398023
[TBL] [Abstract][Full Text] [Related]
15. [Stimulator of interferon genes-associated vasculopathy with onset in infancy: first case report in China].
Yu ZX; Zhong LQ; Song HM; Wang CY; Wang W; Li J; Ma MS
Zhonghua Er Ke Za Zhi; 2018 Mar; 56(3):179-185. PubMed ID: 29518827
[No Abstract] [Full Text] [Related]
16. STING-associated vasculopathy develops independently of IRF3 in mice.
Warner JD; Irizarry-Caro RA; Bennion BG; Ai TL; Smith AM; Miner CA; Sakai T; Gonugunta VK; Wu J; Platt DJ; Yan N; Miner JJ
J Exp Med; 2017 Nov; 214(11):3279-3292. PubMed ID: 28951494
[TBL] [Abstract][Full Text] [Related]
17. A Human Gain-of-Function STING Mutation Causes Immunodeficiency and Gammaherpesvirus-Induced Pulmonary Fibrosis in Mice.
Bennion BG; Ingle H; Ai TL; Miner CA; Platt DJ; Smith AM; Baldridge MT; Miner JJ
J Virol; 2019 Feb; 93(4):. PubMed ID: 30463976
[TBL] [Abstract][Full Text] [Related]
18. Stimulator of Interferon Genes-Associated Vasculopathy With Onset in Infancy: A Mimic of Childhood Granulomatosis With Polyangiitis.
Munoz J; Rodière M; Jeremiah N; Rieux-Laucat F; Oojageer A; Rice GI; Rozenberg F; Crow YJ; Bessis D
JAMA Dermatol; 2015 Aug; 151(8):872-7. PubMed ID: 25992765
[TBL] [Abstract][Full Text] [Related]
19. Influenza A virus targets a cGAS-independent STING pathway that controls enveloped RNA viruses.
Holm CK; Rahbek SH; Gad HH; Bak RO; Jakobsen MR; Jiang Z; Hansen AL; Jensen SK; Sun C; Thomsen MK; Laustsen A; Nielsen CG; Severinsen K; Xiong Y; Burdette DL; Hornung V; Lebbink RJ; Duch M; Fitzgerald KA; Bahrami S; Mikkelsen JG; Hartmann R; Paludan SR
Nat Commun; 2016 Feb; 7():10680. PubMed ID: 26893169
[TBL] [Abstract][Full Text] [Related]
20. The activity of disease-causative STING variants can be suppressed by wild-type STING through heterocomplex formation.
Shindo R; Kuchitsu Y; Mukai K; Taguchi T
Front Cell Dev Biol; 2022; 10():1037999. PubMed ID: 36438571
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
